ASCT2 overexpression is associated with poor survival of OSCC patients and ASCT2 knockdown inhibited growth of glutamine‐addicted OSCC cells
Abstract Background Alanine‐serine‐cysteine transporter 2 (ASCT2), a major glutamine transporter, is essential for cell growth and tumor development in a variety of cancers. However, the clinicopathological significance and pathological role of ASCT2 in OSCC (oral squamous cell carcinoma) lesions re...
Main Authors: | Yijun Luo, Wei Li, Zihang Ling, Qinchao Hu, Zhen Fan, Bin Cheng, Xiaoan Tao |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-05-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.2965 |
Similar Items
-
Research Progress of Glutamine Transporter ASCT2 in Cancer
by: WANG Yale, et al.
Published: (2019-03-01) -
Anti‐tumor effects of an antagonistic mAb against the ASCT2 amino acid transporter on KRAS‐mutated human colorectal cancer cells
by: Yuta Hara, et al.
Published: (2020-01-01) -
ASCT2 (SLC1A5)-Deficient Mice Have Normal B-Cell Development, Proliferation, and Antibody Production
by: Etienne Masle-Farquhar, et al.
Published: (2017-05-01) -
Cryo-EM structures of the human glutamine transporter SLC1A5 (ASCT2) in the outward-facing conformation
by: Xiaodi Yu, et al.
Published: (2019-10-01) -
The Human SLC1A5 (ASCT2) Amino Acid Transporter: From Function to Structure and Role in Cell Biology
by: Mariafrancesca Scalise, et al.
Published: (2018-09-01)